Newamsterdam Pharma Company Nv (NAMS)

05:20 AM

What analysts say about NewAmsterdam Pharma Company N.V. stockRobust investment performance - PrintWeekIndia

05:20 AM

06:52 AM

What analysts say about NewAmsterdam Pharma Company N.V. Equity Warrant stockFree Bull & Bear Market Updates - PrintWeekIndia

06:52 AM

Jul 24, 2025

How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs during market volatility - Newser

Jul 24, 2025

Jul 24, 2025

Will NewAmsterdam Pharma Company N.V. Equity Warrant stock split in the near futureBreakout profit opportunities - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

Arizona State Retirement System Buys New Shares in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - Defense World

Jul 23, 2025

Jul 22, 2025

What drives NewAmsterdam Pharma Company N.V. stock priceRapid wealth creation - Autocar Professional

Jul 22, 2025

Jul 22, 2025

What makes NewAmsterdam Pharma Company N.V. stock price move sharplyMassive Gain Ideas - Newser

Jul 22, 2025

Jul 22, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

NewAmsterdam Pharma Company N.V. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives NewAmsterdam Pharma Company N.V. Equity Warrant stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025 - GlobeNewswire

Jul 22, 2025

Jul 22, 2025

Major Alzheimer's Discovery: Cardiovascular Drug Shows Promising Brain Health Benefits in 1,727 Patients - Stock Titan

Jul 22, 2025

Jul 21, 2025

Is NewAmsterdam Pharma Company N.V. Equity Warrant a good long term investmentExceptional return forecasts - Autocar Professional

Jul 21, 2025

Jul 20, 2025

Is NewAmsterdam Pharma Company N.V. a good long term investmentExplosive portfolio gains - jammulinksnews.com

Jul 20, 2025

Jul 19, 2025

why newamsterdam pharma company n.v. equity warrant stock attracts strong analyst attentionFree Risk Assessment Services - Newser

Jul 19, 2025

Jul 19, 2025

When is the best time to buy NewAmsterdam Pharma Company N.V. stockFree Access to Investment Community - Newser

Jul 19, 2025

Jul 19, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated at The Goldman Sachs Group - Defense World

Jul 19, 2025

Jul 18, 2025

How NewAmsterdam Pharma Company N.V. stock reacts to Fed policy changesFree Capital Allocation Plans - Newser

Jul 18, 2025

Jul 17, 2025

Goldman Sachs Initiates Coverage on NewAmsterdam Pharma With Neutral Rating, $27 Price Target - MarketScreener

Jul 17, 2025

Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating By Investing.com - Investing.com South Africa

Jul 17, 2025

Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating - Investing.com Australia

Jul 17, 2025